Search

everythinglearnresearchcommunity

for

Search:↓

Calcium and magnesium levels in hair decrease after taking supplements, indicating early metabolic changes in perimenopausal women.

Increased calcium in hair may signal early bone health issues in menopausal women.

Minoxidil and finasteride are key treatments for hair loss.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Mesotherapy is more effective and preferred for female hair loss than topical minoxidil.

George Ernest Rogers was a notable scientist who made important discoveries about hair and wool proteins.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Fetal environments contain various chemicals that may disrupt hormones.

Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Localized breast cancer can affect skin and hair.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

Trastuzumab may cause tufted hair folliculitis as a side effect.

New method uses hair follicle cells to estimate human body clock phase, potentially improving sleep disorder diagnosis.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

GnRH treatment can reduce breast cancer cell invasion.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

A new method accurately measures cell changes in breast cancer.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.